Tom Frohlich
Chief Executive Officer at Jade Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Jade Biosciences Inc., 1 year.
Jade Biosciences Inc.
Director · Chief Executive Officer
Chief executive roles
Jade Biosciences Inc.
· Chief Executive Officer
Since April 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Jade Biosciences Inc. | Grant or award | +78,750 | — | — |
| May 16, 2025 | Jade Biosciences Inc. | Open-market purchase | +6,000 | $7.40 | $44,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.